Healthcare
Wisconsin’s First Dedicated Emergency Mental Health Facility Opens in La Crosse
Emplify Health by Gundersen opens EmPATH, the state’s first emergency mental health facility, providing dedicated crisis care within 23 hours.
Choosing the Right Oral Rinse: Experts Stress Personalization Over One-Size-Fits-All
Oral care experts advise consumers to select therapeutic rinses based on individual health needs, highlighting the link between oral health and overall wellness.
MindBio Therapeutics Adds AI-Powered Fatigue Detection to Voice-Based Diagnostics Platform
MindBio Therapeutics expands its AI voice diagnostics platform with fatigue recognition technology for high-risk industries, with commercial testing expected in late Q2 2026.
HeartBeam Launches Pilot Study for On-Demand 12-Lead ECG Patch Aimed at Ischemia Detection
HeartBeam Inc. has initiated a pilot study for its investigational on-demand 12-lead ECG patch in coronary artery disease patients, potentially expanding ambulatory cardiac monitoring into ischemia detection within a $2 billion market.
NanoViricides Highlights Broad-Spectrum Antiviral Candidate After Andes Hantavirus Incident on Cruise Ship
NanoViricides points to its clinical-stage antiviral candidate NV-387 as a potential broad-spectrum therapeutic following an Andes hantavirus incident aboard a cruise ship, underscoring the need for versatile antiviral treatments.
Kairos Pharma Sets Virtual Annual Meeting, Discloses Going Concern Notice
Kairos Pharma announced its virtual annual meeting and disclosed a going concern notice in its 2025 annual report, highlighting financial uncertainties for the clinical-stage biopharmaceutical company.
Oncotelic Therapeutics Targets CNS Drug Delivery as Brain Therapeutics Innovation Accelerates
Oncotelic Therapeutics is leveraging its intranasal nose-to-brain delivery platform to address the challenge of delivering therapeutics across the blood-brain barrier, targeting Alzheimer's disease and biodefense applications in a rapidly evolving biopharma landscape.
MindBio Therapeutics Advances AI Voice-Based Intoxication Detection Amid Growing Real-Time Diagnostics Market
MindBio Therapeutics is developing an AI-driven voice analysis platform to detect drug and alcohol intoxication in real time, targeting workplace safety, healthcare, and public safety markets as traditional testing methods face limitations.
SureNano Science Advances GEP-44 as Obesity Drug Market Poised to Exceed $200 Billion
SureNano Science Ltd., through its subsidiary GlucaPharm Inc., is developing GEP-44, a next-generation GLP-1 triple agonist peptide targeting obesity and metabolic disorders, as the global market for such therapies is projected to surpass $200 billion.
SureNano Science Advances Next-Generation GLP-1 Platform with Triple Agonist Peptide GEP-44
SureNano Science Ltd. is developing GEP-44, a novel triple agonist peptide for improved GLP-1 therapy, aiming to address obesity and diabetes alongside major players like Eli Lilly and Novo Nordisk.
CNS Drug Delivery Innovations Address Critical Bottleneck in Biotech Market
Advancements in blood-brain barrier penetration technologies, such as Oncotelic's intranasal nose-to-brain system, are unlocking significant opportunities in the biotech sector by enabling targeted CNS therapies for diseases like Alzheimer's and bolstering biodefense preparedness.
Voice Analysis and AI Could Revolutionize Drug and Alcohol Intoxication Detection
MindBio Therapeutics is developing an AI-powered voice analysis platform to detect real-time impairment from short speech samples, addressing limitations of traditional testing methods.
iOrganBio Appoints AI and Life Sciences Investor Jessica Owens to Board of Directors
iOrganBio has appointed Jessica Owens, a seasoned venture investor and co-founder of GRAIL, to its board to help scale its AI-driven cell manufacturing platform.
DOJ Launches Task Force to Curb Tech-Driven Health Care Fraud on West Coast
The U.S. Department of Justice announced a task force targeting tech-driven health care fraud in California, Arizona, and Nevada, aiming to dismantle digital health schemes and improve conditions for legitimate providers like Astiva Health.
AI-Powered Wearables Poised to Transform Healthcare with Actionable Insights
Advances in artificial intelligence are enabling wearable devices to provide clinicians with actionable insights, moving beyond data collection to drive meaningful healthcare improvements.
KALA BIO Implements 1-for-50 Reverse Stock Split, Reducing Outstanding Shares from 929.5 Million to 18.6 Million
KALA BIO executed a 1-for-50 reverse stock split to meet Nasdaq listing requirements and consolidate its capital structure, effective May 11, 2026.
Pipeline Maturity Reshapes Biotech Valuations as Clinical Progress Gains Weight
The biotechnology industry's valuation model is shifting from a revenue-centric approach to one that prioritizes clinical-stage progression and probability of success, with companies like Oncotelic Therapeutics exemplifying this trend.
Gillian Ragan Foundation to Host First Community Fundraiser at Pinnacle Brewing Company
The Gillian Ragan Foundation, supporting families who lost a child, will hold its inaugural fundraiser on May 17, 2026, featuring a hybrid silent auction to fund mental health therapy and grief counseling.
MedCognetics and AWS Partner to Bring AI-Powered Breast Cancer Screening to Underserved Indian Communities
MedCognetics collaborates with AWS and Health Within Reach Foundation to deploy AI-enabled mobile mammography units in India, aiming to reduce breast cancer disparities in underserved populations.
Lantern Pharma Unveils Multi-Agent AI and Computational Biology Tools for withZeta.ai Platform
Lantern Pharma announced the next phase of its withZeta.ai platform, including ZetaSwarm and ZetaOmics, which could accelerate oncology research and create a new revenue stream for the company.
Silo Pharma Launches Ibogaine-Based TBI Therapeutics Initiative
Silo Pharma announced a strategic initiative to develop ibogaine-based therapeutics for traumatic brain injury and related conditions, filing a provisional patent application.
NextPlat Corp to Report First-Quarter 2026 Financial Results on May 14
NextPlat Corp announced it will release its Q1 2026 financial results on May 14, 2026, providing investors with key insights into the company's performance in its e-commerce and healthcare solutions segments.
Oragenics Signs LOI to License CardioDialysis Technology for Brain Disorders
Oragenics Inc. has signed a letter of intent to license Sigyn Therapeutics' CardioDialysis blood purification technology, aiming to combine it with its intranasal neurosteroid candidate ONP-002 for a dual-modality approach to traumatic brain injury and neurodegenerative diseases.
HeartBeam Expands Concierge Cardiology Footprint with Atelier Health Agreement
HeartBeam Inc. has signed a commercial agreement with Beverly Hills-based Atelier Health, expanding its launch footprint into Southern California and completing its initial targeted markets for its cable-free 3D ECG technology.
Hantavirus Outbreak on Cruise Ship Raises Concerns Over Little-Known Infection
A hantavirus outbreak on the MV Hondius cruise ship has resulted in three fatalities, highlighting the need for awareness and diagnostic solutions for this rare but deadly virus.
NanoViricides to Present at D. Boral Capital Global Conference Amid Progress on Broad-Spectrum Antiviral NV-387
NanoViricides will participate in the D. Boral Capital Global Conference, highlighting its clinical-stage antiviral drug NV-387 and its potential to treat multiple viral infections including RSV, COVID, and Monkeypox.
Annovis Bio CEO to Present Multi-Protein Approach to Alzheimer's at Fierce Biotech Week 2026
Annovis Bio CEO will present the company's multi-protein targeting strategy for Alzheimer's disease at Fierce Biotech Week 2026, highlighting buntanetap's Phase 3 trial.
Wellness Index Report Highlights Shift from Seasonal Diets to Cellular Health as Superhuman Protocol Challenge Gains Traction
The April 2026 Wellness Index Report reveals a consumer shift from short-term weight loss to cellular-level health optimization, spotlighting the Superhuman Protocol Challenge and three top-rated providers.
Wellness Index Report Reveals Top Providers in Superhuman Protocol Challenge, Marking Shift to Cellular-Level Health
The April 2026 Wellness Index Report identifies Physical Evidence Chiropractic, Boro Holistic Health, and April Berkowitz as leading providers in the Superhuman Protocol Challenge, signaling a move from seasonal weight-loss trends to system-level health optimization.
AI and Multi-Omics Converge: Cardio Diagnostics Targets Earlier, More Precise Cardiac Insights
Cardio Diagnostics Holdings is leveraging artificial intelligence and multi-omic biomarkers to improve early detection and personalized treatment of cardiovascular disease, addressing a critical gap in traditional risk assessment.